EBGLYSS FDA approval date

The FDA approved EBGLYSS on 13 Sep 2024.

FDA approval date
13 Sep 2024

Drug identity has not yet been verified against registry records

Also recorded as LEBRIKIZUMAB-LBKZ

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2024-09-13DayEBGLYSSFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761306", "applicant_as_listed_by_fda": "ELI LILLY AND CO", "brand_names": ["EBGLYSS"], "active_ingredients": ["LEBRIKIZUMAB-LBKZ"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20240913", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026